Hepatitis E Virus in immunosuppressed patients in the era of global mobility

Hepatitis E virus (HEV) has emerged as a major, yet under-recognized, public health challenge worldwide, particularly in the context of increasing global mobility and expanding populations of immunosuppressed individuals. Zoonotic HEV, now the leading cause of acute viral hepatitis in Europe, is hindered by markedly heterogeneous surveillance systems, diagnostic strategies, and preventive policies, which limit cross-country comparability obscuring the true disease burden. Underdiagnosis is compounded by the existence of extrahepatic manifestations that escape conventional hepatotropic case definitions. At the same time, chronic HEV infection has gained clinical relevance among immunocompromised hosts, including solid organ transplant recipients, patients with hematologic malignancies, and those receiving biologic or other immunomodulatory therapies. However, the mechanisms driving viral persistence, progression to chronicity, and optimal antiviral management remain incompletely defined. This review synthesizes current epidemiological, clinical, and virological knowledge on HEV in Europe, with a focus on the implications of global migration, and the growing population at risk due to immunosuppression. It highlights key gaps and priority areas, particularly the management of infection in immunocompromised hosts and the development and implementation of targeted vaccination strategies for high-risk groups. In conclusion, integrated cross-disciplinary action is needed in response to this emerging threat.

Authors

Institutions

Publication Details

Journal
Seminars in Liver Disease
Published
2026-11-12
DOI
https://doi.org/10.1055/a-2996-6521
Primary Topic
Hepatitis Viruses Studies and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Hepatitis E Virus in immunosuppressed patients in the era of global mobility

Susanne Gjeruldsen Dudman, Antonio Rivero‐Juárez, Nassim Kamar, Mia Blažević et al.
Seminars in Liver Disease
Hepatitis Viruses Studies and Epidemiology
article

Hepatitis E Virus in immunosuppressed patients in the era of global mobility

Susanne Gjeruldsen Dudman, Antonio Rivero‐Juárez, Nassim Kamar, Mia Blažević, Imran Hassanoglu
article en

Abstract

Hepatitis E virus (HEV) has emerged as a major, yet under-recognized, public health challenge worldwide, particularly in the context of increasing global mobility and expanding populations of immunosuppressed individuals. Zoonotic HEV, now the leading cause of acute viral hepatitis in Europe, is hindered by markedly heterogeneous surveillance systems, diagnostic strategies, and preventive policies, which limit cross-country comparability obscuring the true disease burden. Underdiagnosis is compounded by the existence of extrahepatic manifestations that escape conventional hepatotropic case definitions. At the same time, chronic HEV infection has gained clinical relevance among immunocompromised hosts, including solid organ transplant recipients, patients with hematologic malignancies, and those receiving biologic or other immunomodulatory therapies. However, the mechanisms driving viral persistence, progression to chronicity, and optimal antiviral management remain incompletely defined. This review synthesizes current epidemiological, clinical, and virological knowledge on HEV in Europe, with a focus on the implications of global migration, and the growing population at risk due to immunosuppression. It highlights key gaps and priority areas, particularly the management of infection in immunocompromised hosts and the development and implementation of targeted vaccination strategies for high-risk groups. In conclusion, integrated cross-disciplinary action is needed in response to this emerging threat.

Seminars in Liver Disease
Oslo University Hospital (NO), Ministry of Health (TR), Université Toulouse III - Paul Sabatier (FR), Inserm (FR), University of Oslo (NO), Instituto de Salud Carlos III (ES), Centre Hospitalier Universitaire de Toulouse (FR), Instituto Maimónides de Investigación Biomédica de Córdoba (ES), Ankara Yıldırım Beyazıt University (TR), Ankara Bilkent City Hospital (TR)
European Cooperation in Science and Technology
Good health and well-being
Hepatitis Viruses Studies and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon